[Cathie Wood: AI Will Have the Most Profound Applications in Healthcare] Odaily Planet Daily reported that Cathie Wood posted on the X platform, stating that according to ARKInvest's research, the most profound applications of AI will be in healthcare. Deregulation is accelerating this transformation in the healthcare sector. Significant progress has been made in the science of evaluating drug efficacy, with research projects collecting evidence from multiple dimensions such as mechanisms of action, biomarker effects, and intermediate endpoints. These validation evidences, ranging from mechanistic data to real-world evidence, can replace the second critical trial. Historically, there has been considerable regulatory flexibility in the fields of rare diseases and oncology. It is expected that this shift from two trials to one will have the greatest impact on common diseases such as cardiovascular and respiratory conditions, potentially saving up to $350 million per project and shortening the R&D cycle by several years.